ARCTArcturus Therapeutics
About Arcturus Therapeutics
Arcturus Therapeutics (NASDAQ:ARCT) is a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines. The company leverages its proprietary lipid nanoparticle delivery system and RNA platforms to develop novel therapeutics. Arcturus’s projects include treatments for cystic fibrosis, liver diseases, and a diverse pipeline of mRNA vaccines against infectious diseases. The objective of Arcturus is to harness the potential of RNA therapies to address unmet medical needs and improve patient outcomes through its innovative research and development efforts.
What is ARCT known for?
Snapshot
Public US
Ownership
2008
Year founded
200
Employees
California, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Produtos e/ou serviços de Arcturus Therapeutics
- LUNAR-COV19 (ARCT-021), a vaccine candidate designed to prevent COVID-19 using self-amplifying mRNA technology.
- LUNAR-OTC, aiming to treat Ornithine Transcarbamylase (OTC) Deficiency by delivering OTC mRNA to liver cells.
- LUNAR-CF, focused on treating Cystic Fibrosis through the delivery of mRNA to the lungs to enable CFTR protein production.
- ARCT-810, an mRNA therapeutic candidate targeting Ornithine Transcarbamylase Deficiency, utilizing LUNAR lipid-mediated delivery to enhance protein expression.
- Preclinical pipeline including various mRNA-based therapeutic and vaccine candidates targeting infectious diseases and rare disorders.
equipe executiva do Arcturus Therapeutics
- Mr. Joseph E. Payne M.Sc.Founder, President, CEO & Director
- Dr. Padmanabh Chivukula Ph.D.Founder, Chief Scientific Officer, COO & Secretary
- Mr. Lance KurataChief Legal Officer
- Mr. Joseph RobertsInterim Principal Financial & Accounting Officer and Controller
- Ms. Neda SafarzadehVice President and Head of IR/PR & Marketing
- Ms. Natasha O. BowmanChief Human Resources Officer
- Mr. Kevin T. SkolChief Business Officer
- Dr. Igor Smolenov M.D., Ph.D.Chief Development Officer
- Dr. Ye ZhangChief Regulatory Officer
- Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D.Chief Medical Officer